New nomenclature for fatty liver disease.
Ugeskr Laeger
; 186(19)2024 May 06.
Article
de Da
| MEDLINE
| ID: mdl-38808766
ABSTRACT
This review investigates that, in 2023, fatty liver disease underwent a name change to "steatotic liver disease" (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic and alcohol-related liver disease (MetALD). The renaming aims to better incorporate alcohol intake and metabolic risk factors into disease classification and to diminish the stigma associated with the previous nomenclature. Early identification of the patient's aetiology is important for the prognosis which can be improved by interventions against the causative risk factors.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Terminologie comme sujet
Limites:
Humans
Langue:
Da
Journal:
Ugeskr Laeger
/
Ugeskr. laeg
/
Ugeskrift for laeger
Année:
2024
Type de document:
Article
Pays de publication:
Danemark